Phase 1 Dose Escalation Trial of Intra-Tumoral Injection of Sodium Iodide Simporter (NIS) Measles Virus (Edmonston Strain) in Combination With Atezolizumab in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2018
At a glance
- Drugs Atezolizumab (Primary) ; MV NIS (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Vyriad
- 09 Mar 2018 Status changed from recruiting to discontinued.
- 03 Aug 2017 Status changed from not yet recruiting to recruiting.
- 03 Oct 2016 New trial record